This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slipped 3.6% to $1.06 on what proved to be an all-around grim trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 52,218.58 and the NASDAQ Composite Index falling 0.6% to 25,690.90.
Inovio Pharmaceuticals Inc. closed 64.4% short of its 52-week high of $2.98, which the company achieved on September 9th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 2.0% to $255.63, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.48% to $24.82.
Trading volume totaled 968,408, compared to the 50-day average of 2.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 22, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.